This trial will investigate whether genes and cognitive abilities predict responsiveness to aphasia therapy for word-retrieval difficulties.
2 Primary · 2 Secondary · Reporting Duration: 4 months
1 Treatment Group
Single Arm Treatment
1 of 1
120 Total Participants · 1 Treatment Group
Primary Treatment: Cued picture-naming therapy · No Placebo Group · N/A
Who is running the clinical trial?
Age 18 - 85 · All Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
Does the protocol for this trial permit enrolment of persons below thirty years old?
"This clinical trial has an age limit of 18 or above and 85 or below for prospective participants." - Anonymous Online Contributor
Is it possible to enlist in this clinical research endeavor?
"To be eligible for this research, candidates must have an aphasic diagnosis and fall within the 18 to 85 age bracket. The trial aims to enrol 120 individuals in total." - Anonymous Online Contributor
What is the current number of participants enrolled in this clinical study?
"Affirmative. According to clinicaltrials.gov, recruitment for this medical trial is ongoing since its initiation on October 23rd 2020 and the most recent update made on September 2nd 2022. The study requires 120 participants from a single site." - Anonymous Online Contributor
Is the recruitment process for this medical trial still open?
"Affirmative. According to the information hosted on clinicaltrials.gov, this research initiative which was first published on October 23rd 2020 is actively recruiting participants. The enrolment of 120 patients from a single site needs to be completed soon." - Anonymous Online Contributor